Naphthoquinone anti-psoriatic agents
US4419368A · kind A · utility
6Cited by
2References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 2, 1981 |
| Grant date | Dec 6, 1983 |
| Priority date | — |
| Expiry date | Nov 2, 2001 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C46/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Psoriasis in mammals is relieved by topically administering substituted naphthoquinone of the formula: ##STR1## wherein: R.sup.3 is halo, linear or branched alkoxy of one to eighteen carbon atoms or --S(O).sub.n R wherein: PA0 n is 0, 1 or 2; and PA0 R is a alkyl of one to eighteen carbon atoms, alkoxycarbonylalkyl, optionally substituted phenyl, optionally substituted phenylalkyl or optionally substituted heterocyclic aryl and the pharmaceutically acceptable salts of said heterocyclic aryl.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.